N

Neogen Chemicals Limited

NEOGENNSE
Market snapshot · 2026-08-11 04:14 UTC

2,120.40

₹-62.40 (-2.86%)

MARKET CAP

₹5.81K Cr

STOCK P/E

149.4x

52W HIGH

₹2,374.00

52W LOW

₹966.70

BOOK VALUE

₹309.59

EPS

₹14.19

ROE

SECTOR

Materials

DEBT/EQUITY

170.92

VOLUME

42,863

P/B RATIO

6.85x

PEG RATIO

2.42

Sector

Materials

Themes

Specialty Chemicals
D
Dividend
E
Earnings
₹2,175.60₹1,895.38₹1,615.15₹1,334.93₹1,054.70VolumeDEEEEAug '25Sep '25Nov '25Jan '26Mar '26Apr '26Jun '26Aug '26

AI Summary

✦ Clartha

Neogen Chemicals is a specialty chemicals manufacturer producing organo bromine, speciality chloro and organo lithium compounds. These products serve industrial applications, while inorganic chemicals add another revenue stream. Revenue grew 12.2% year-on-year, but profit declined 17.5%, indicating limited earnings conversion despite stable margins. Recent battery-localisation interest could support demand for specialty chemicals, although disclosed information does not quantify its margin impact. ROE is unavailable, preventing a direct return assessment; stable margins contrast with weaker profit growth. Debt-to-equity of 170.91x implies extreme leverage, which can amplify ROE volatility and constrain financial flexibility. At 153.8x earnings, Neogen appears richly valued and trades at a substantial premium to its 12.2% growth rate. The central open question is whether battery-linked demand can justify this valuation while leverage remains elevated.

Valuation Metrics

Trading 36.2% above historical median. Valuation is declining — currently in the strongly overvalued zone (z-score: +1.84). Confidence: 83%.

Live forward EPS implies next-12-month EPS of ₹57.80. Applying the stock's normalized valuation corridor produces a fair range of ₹5,884.04 to ₹7,130.79, with base value near ₹6,342.39 (+199.0% vs current price).

Forward Valuation Outlook

Live forward estimate anchored to the company's historical valuation corridor.

Below normalized range

Forward EPS

₹57.80

Forward P/E

36.7x

Base Fair Value

₹6,342.39

Fair Range

₹5,884.04 - ₹7,130.79

Upside To Base

+199.0%

Estimate Source

Live forward EPS

Growth Estimate

+61.7%

P/E
Strongly Overvalued

5Y Average

109.30

Current

149.42

Overvalued

123.37

Undervalued

101.80

EV/EBITDA
Strongly Overvalued

5Y Average

34.97

Current

47.81

Overvalued

37.39

Undervalued

31.11

P/B
Strongly Overvalued

5Y Average

5.32

Current

6.85

Overvalued

6.12

Undervalued

4.52

Peers & Comparison

Sector: Materials · Theme: Specialty Chemicals

Specialty Chemicals Peers8 peers
Avg P/E: 47.3x
CompanyRev. GrowthMarginP/Evs Avg52W Perf.
SUPREME PETROCHEM LIMITED
SPLPETROSpecialty Chemicals
+23.7%8.5%
26.9x
Undervalued
-43% vs avg
-4.3%
ALKYL AMINES CHEM. LTD
ALKYLAMINESpecialty Chemicals
-4.6%11.8%
43.6x
Fair
-8% vs avg
-8.7%
CLEAN SCIENCE & TECH LTD
CLEANSpecialty Chemicals
+10.5%23.7%
36.3x
Undervalued
-23% vs avg
-30.7%
GALAXY SURFACTANTS LTD
GALAXYSURFSpecialty Chemicals
+14.8%5.1%
27.1x
Undervalued
-43% vs avg
-14.4%
AETHER INDUSTRIES LIMITED
AETHERSpecialty Chemicals
+27.5%19.1%
89.9x
Premium
+90% vs avg
+116.4%
ANUPAM RASAYAN INDIA LTD
ANURASSpecialty Chemicals
+27.5%7.2%
78.7x
Premium
+66% vs avg
+6.7%
FINE ORGANIC IND. LTD.
FINEORGSpecialty Chemicals
+22.1%17.8%
37.5x
Undervalued
-21% vs avg
+5.6%
JUBILANT INGREVIA LIMITED
JUBLINGREASpecialty Chemicals
+25.3%6.6%
38.5x
Undervalued
-19% vs avg
+6.4%
WHY THESE PEERS

NEOGEN CHEMICALS LIMITED trades at a premium (149.5x vs peer avg 47.3x), implying higher growth or quality expectations from the Specialty Chemicals cohort. Peers include SUPREME PETROCHEM LIMITED, ALKYL AMINES CHEM. LTD, CLEAN SCIENCE & TECH LTD — selected based on business model, industry classification, market cap similarity, and business theme alignment.

Financials

Financial chart data is not available for this company right now.

Results

Income statement data not available.

All values in ₹ Crores unless otherwise stated. Source: Company filings.

Loading shareholding pattern...